PORTLAND, Ore.--(BUSINESS WIRE)--CortControl, a medical food formulator, executives from PATH, a leader in global health innovation and MJ Murdock Charitable Trust will join forces to convene a “Northwest – Driving Global Health Innovation” evening in Portland, Oregon on Nov. 9.
The evening brings together a unique blend of philanthropists, medical innovators and researchers and technologists to look at innovations in global health and provide a venue to discuss strategies to accelerate these innovations for maximum health impact.
PATH’s mantra of “driving transformative innovation to save lives” leverages world-class capability in vaccines, medical devices and tools, drugs, diagnostics and the systems services needed to deliver them across four continents.
“The Pacific Northwest has become an international hub of technology and global heath expertise and philanthropic support, so Portland was a logical choice to host such an event,” says PATH’s Amie Batson, Chief Strategy Officer. “By bringing together different people with shared passion for improving global health, we’re hoping to move the needle in very real and positive ways.”
CortControl is the event sponsor. CEO and Founder, Jim Daniels, summed up their involvement, thusly, “We share PATH’s vision of leveraging innovation to improve global health and mobilizing emerging technologies is critical to that vision. Our vaccine enhancement regime has the potential to have a dramatic impact on the effectiveness of treating people in developing countries, we just have to get it to them.”
“The idea of such a relatively informal gathering is to encourage collaboration and advancement of big ideas that will continue to drive innovation in vital global health initiatives,” says Batson. “It will be exciting to see where this goes.”
About CortControl
CortControl is dedicated to the formulation of innovative treatments that address chronic human illnesses globally and for the betterment of humankind. CortControl develops market-ready patent-protected medical foods for manufacture and distribution. CortControl’s Glutrasol™ family of products, when combined with other specific medical protocols, like vaccine regimes, infertility treatments and others, work to improve immune function to dramatically improve the efficacy of those protocols. CortControl is committed to advancing global health by sharing emerging technologies and vision with donors, tech researchers, manufacturers and delivery organizations. Learn more at www.cortcontrol.com.
